Tissue Engineering

FDA Clears AD-NP1 for Heart Failure Clinical Trials
Biotech & Bioprocessing FDA Clears AD-NP1 for Heart Failure Clinical Trials

Heart failure remains a formidable challenge in modern medicine, affecting millions globally and often leading to a diminished quality of life due to the heart's inability to pump blood effectively after injury. A groundbreaking development has emerged with the U.S. Food and Drug Administration

Nicheformer Redefines Cellular Interaction in Tissues
Tech & Innovation Nicheformer Redefines Cellular Interaction in Tissues

The field of computational biology stands at a pivotal moment, where the ability to decode cellular behavior within tissues is transforming medical and scientific understanding, and this discipline, blending biology with advanced data analytics, has become instrumental in uncovering how cells

How Does Lipid Reprogramming Drive Renal Cancer Therapy?
Biotech & Bioprocessing How Does Lipid Reprogramming Drive Renal Cancer Therapy?

Lipid reprogramming has emerged as a critical frontier in understanding and treating clear cell renal cell carcinoma (ccRCC), the predominant subtype of kidney cancer that accounts for a significant portion of cases worldwide. This metabolic transformation, where tumor cells drastically alter how

Common Skin Virus Linked to Cancer Growth in New Study
Biotech & Bioprocessing Common Skin Virus Linked to Cancer Growth in New Study

In a stunning revelation that has sent ripples through the medical community, a recent study published in The New England Journal of Medicine has uncovered a direct link between a widespread skin virus and the development of a common form of skin cancer. The research spotlights betapapillomavirus

Recombinant Human Collagen III Transforms Tissue Engineering
Biotech & Bioprocessing Recombinant Human Collagen III Transforms Tissue Engineering

In the rapidly evolving landscape of regenerative medicine, a groundbreaking biomaterial known as recombinant human type III collagen (rhCol III) is capturing the attention of scientists and medical professionals alike, marking a significant advancement. This innovative substance, crafted through

Mogamulizumab Boosts Survival in Rare Skin Cancers
Biotech & Bioprocessing Mogamulizumab Boosts Survival in Rare Skin Cancers

In a landscape where rare diseases often struggle for attention and innovation, cutaneous T-cell lymphoma (CTCL)—encompassing mycosis fungoides (MF) and Sézary syndrome (SS)—stands as a stark reminder of unmet medical needs. With only a small fraction of cancer cases attributed to these conditions,

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later